Restoring eye health by further understanding and rebalancing of the immune system.
Using advances in genetics to develop personalised interventions, including gene therapies, for a wide range of ocular conditions.
Developing cell-based therapies and diagnostics; controlling scar repair and restoring function with biodevices and new technology; improving current therapies and drug delivery for global benefit.
Harnessing the huge wealth of ophthalmic data characterising human ophthalmic diversity at a population level and delivering this data to the other themes, as well as digital and therapeutic innovations at the clinical level.
Using innovations in medical imaging and artificial intelligence (A.I.) to assess the structure and function of the eye in great detail, and applying these across the other themes at the level of both clinical care and research.